REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 53 filers reported holding REGULUS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $35,000 | -70.1% | 177,600 | 0.0% | 0.00% | – |
Q2 2018 | $117,000 | -7.9% | 177,600 | 0.0% | 0.00% | – |
Q1 2018 | $127,000 | -31.4% | 177,600 | 0.0% | 0.00% | – |
Q4 2017 | $185,000 | -16.7% | 177,600 | 0.0% | 0.00% | – |
Q3 2017 | $222,000 | +26.9% | 177,600 | 0.0% | 0.00% | – |
Q2 2017 | $175,000 | -40.3% | 177,600 | 0.0% | 0.00% | – |
Q1 2017 | $293,000 | -29.7% | 177,600 | -4.2% | 0.00% | -100.0% |
Q4 2016 | $417,000 | -35.1% | 185,300 | -4.8% | 0.00% | 0.0% |
Q3 2016 | $643,000 | +7.0% | 194,700 | -6.4% | 0.00% | 0.0% |
Q2 2016 | $601,000 | -59.6% | 208,100 | -3.0% | 0.00% | -50.0% |
Q1 2016 | $1,487,000 | -25.1% | 214,600 | -5.7% | 0.00% | -33.3% |
Q4 2015 | $1,985,000 | +33.3% | 227,600 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,489,000 | +185.2% | 227,600 | +378.2% | 0.00% | +200.0% |
Q2 2015 | $522,000 | -42.0% | 47,600 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $900,000 | 0.0% | 47,600 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $900,000 | +176.9% | 47,600 | 0.0% | 0.00% | – |
Q3 2014 | $325,000 | -15.1% | 47,600 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $383,000 | +15.0% | 47,600 | +9.7% | 0.00% | – |
Q1 2014 | $333,000 | +6560.0% | 43,400 | +8580.0% | 0.00% | – |
Q3 2013 | $5,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2013 | $5,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|